February 19, 2021
February brings good news for people who don’t have health insurance. Due to a special enrollment period, the federal insurance marketplace is once again open for people to sign up for private coverage.
June 30, 2020
Lawmakers in South Dakota and Louisiana didn’t let the coronavirus derail their efforts to protect patients.
January 21, 2020
Stress is a common response to skin conditions. It may also be making those skin conditions worse.
January 16, 2020
Health care providers say that regulators could do more to enforce commonsense limits on prior authorization and step therapy, according to a new series of reports from the Aimed Alliance.
December 16, 2019
As a dermatologist, it is my job to take the clues the skin provides and interpret these to do my very best to diagnose, monitor and treat my patients. Insurance companies sometimes make that difficult.
October 10, 2019
A new bill introduced in the U.S. Senate would curb the health plan practice of requiring patients to try and fail an insurer-preferred drug before getting the one their doctor prescribed.
June 7, 2019
Elated. Nervous. Hopeful. That’s how thousands of cystic fibrosis patients felt upon hearing last week’s news: the Food and Drug Administration will soon review a new triple combination therapy that could drastically improve their quality of life.
May 29, 2019
Most people have a stereotypical perception of Tourette syndrome. Likely based on a movie or TV show, their vision is of an uncontrollable stream of insults and curse words. On the screen, these symptoms become the joke, the punchline. Yet cliché portrayals of Tourette syndrome are not only oversimplified, but also harmful.
May 29, 2019
Cancer patients are breathing a sigh of relief. So are patients with movement disorders. And those with epilepsy, HIV and…
February 25, 2019
Paul has been coming to our dermatology office for years. He has painful psoriasis; after years of trying different medications he finally found one that controls his symptoms. Then Paul changed insurance companies in the middle of his treatment.